Does GLOFITAMAB-GXBM Cause Condition aggravated? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Condition aggravated have been filed in association with GLOFITAMAB-GXBM. This represents 2.4% of all adverse event reports for GLOFITAMAB-GXBM.
12
Reports of Condition aggravated with GLOFITAMAB-GXBM
2.4%
of all GLOFITAMAB-GXBM reports
11
Deaths
0
Hospitalizations
How Dangerous Is Condition aggravated From GLOFITAMAB-GXBM?
Of the 12 reports, 11 (91.7%) resulted in death.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB-GXBM. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB-GXBM Cause?
Cytokine release syndrome (107)
Disease progression (68)
Off label use (68)
Death (67)
Pyrexia (45)
No adverse event (28)
Immune effector cell-associated neurotoxicity syndrome (25)
Infection (20)
Pneumonia (14)
Covid-19 (10)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which GLOFITAMAB-GXBM Alternatives Have Lower Condition aggravated Risk?
GLOFITAMAB-GXBM vs GLUCAGON
GLOFITAMAB-GXBM vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB-GXBM vs GLUCARPIDASE
GLOFITAMAB-GXBM vs GLUCOPHAGE
GLOFITAMAB-GXBM vs GLUCOSAMINE